Pityriasis Rotunda
Clinical guidelines for managing acquired circular scaling dermatoses, evaluating underlying malignancy and systemic associations, and reviewing topical keratolytics.
Table of Contents
π§ Standard of Care & Symptoms
Pityriasis Rotunda is an extremely rare, acquired cutaneous disorder characterized by large, perfectly circular, scaling lesions that serve as a cutaneous marker for underlying systemic pathology.
- Presentation: Key dermatological findings.
- Perfectly Circular Patches: Presents as single or multiple, sharply demarcated, perfectly round or oval patches ranging from 2 cm to > 20 cm in diameter.
- Pigmentation Shifts: Patches are typically hyperpigmented (darker, brown) in dark-skinned individuals, or hypopigmented/pinkish in light-skinned patients.
- Scaling and Symptoms: Features a fine, adherent, cigarette-paper-like scale. The patches are completely asymptomatic (no itching, burning, or pain). Located primarily on the trunk, buttocks, and thighs.
- Systemic Associations: The condition is considered a paraneoplastic syndrome or cutaneous sign of systemic illness. Strongly associated with internal malignancies (hepatocellular carcinoma, gastric adenocarcinoma, esophageal cancer, leukemia), chronic infections (tuberculosis, leprosy), liver cirrhosis, pulmonary diseases, and severe malnutrition.
π¬ Diagnostics & Systemic Screenings
Because pityriasis rotunda is a cutaneous manifestation of internal disease, clinical confirmation must trigger a comprehensive systemic evaluation.
- Skin Biopsy: Punch biopsy reveals non-specific features: mild hyperkeratosis, thinned or absent granular layer, and increased melanin deposition in the basal layer of hyperpigmented lesions. Dermal inflammation is absent. Differentiates it from acquired ichthyosis or tinea corporis.
- Systemic Workup: Mandatory diagnostic screenings.
- Infectious Screen: Chest X-ray, sputum cultures, and tuberculin skin tests to rule out active or latent tuberculosis.
- Malignancy Screen: Complete blood count, liver function panels (hepatocellular carcinoma risk), abdominal ultrasound, and age-appropriate cancer screenings.
Histopathology Details & Nutritional/Malabsorptive Mechanisms
The circular plaques of pityriasis rotunda are cellular signatures of metabolic or cachectic systemic stress:
- Stratum Granulosum Attenuation: Histology shows mild to moderate orthokeratotic hyperkeratosis coupled with thinning or complete absence of the granular layer (stratum granulosum). There is an absence of dermal inflammation, perivascular cuffing, or exocytosis, distinguishing it from inflammatory scaly dermatoses.
- Retinoid Deficits & Malabsorption: Lesions are believed to represent a localized form of acquired **vitamin A deficiency** or defect in **retinoid-binding proteins**. Systemic infections (tuberculosis) or visceral malignancies disrupt liver storage of vitamin A and impair intestinal absorption, leading to localized keratinization abnormalities.
π Underlyling Disease Care & Topical Keratolytics
Therapy focuses primarily on diagnosing and treating the underlying systemic infection or tumor. The skin patches typically resolve completely once the primary condition is treated.
Primary Systemic Treatment
- Resolution of Associated Pathology: Targeted cancer chemotherapy, surgical tumor resection, or appropriate anti-tuberculous/anti-microbial drug regimens generally lead to spontaneous clearance of the circular skin patches within months.
Topical Symptomatic Support
- Topical Keratolytics (Urea or Salicylic Acid): Ointments containing 10% to 20% urea or 3% to 6% salicylic acid can be used to hydrate the skin and reduce dry, adherent scaling.
- Topical Retinoids (e.g., Tretinoin): Helps normalize epidermal proliferation in idiopathic cases that lack an underlying systemic cause.
π¬ Active Clinical Trials
Clinical trials are currently evaluating screening algorithms for paraneoplastic syndromes, the prevalence of underlying active tuberculosis in pityriasis rotunda cohorts, and efficacy of topical retinoid formulations.
A multi-center observational registry tracking the rates of internal malignancy discovery following a standardized diagnosis of pityriasis rotunda.
Key Inclusion: Age ≥ 18, presenting with one or more perfectly circular/oval hyperpigmented scaling patches ≥ 5 cm in diameter, pathologically confirmed pityriasis rotunda on skin biopsy, and willing to undergo screening workup.Evaluating the diagnostic yield of systemic tuberculosis screening in patients presenting with circular scaling patches.
Key Inclusion: Age ≥ 12, biopsy-confirmed pityriasis rotunda, no history of treated tuberculosis, and scheduled for systemic screening including QuantiFERON gold assay and chest radiograph.Testing the efficacy of topical tazarotene gel versus salicylic acid ointment in idiopathic, benign pityriasis rotunda.
Key Inclusion: Age 18 to 70, diagnosed with idiopathic pityriasis rotunda (defined as no associated malignancies or chronic systemic infections on full workup), and having bilateral/symmetric dry scaling plaques.πΊοΈ Next Steps After Diagnosis
If you have recently been diagnosed with Pityriasis Rotunda, implement these medical care steps:
- Confirm via Skin Biopsy: Differentiate the circular lesions from tinea corporis or acquired ichthyosis via punch biopsy.
- Schedule a Comprehensive Physical Exam: Consult an internist or primary care physician immediately for a thorough systemic evaluation.
- Undergo Tuberculosis and Cancer Screening: Complete blood tests, liver function panels, chest imaging, and abdominal ultrasounds to check for underlying chronic infections or tumors.
- Apply Topical Hydrating Agents: Apply urea-based or salicylic acid emollients twice daily to manage the scaling while systemic tests are completed.
β Patient FAQ
Q: Why is my doctor ordering so many tests for a simple skin spot?
A: Pityriasis rotunda is highly unique because the skin lesions themselves are completely harmless, but they are very frequently a "red flag" or sign of an underlying internal disease. Up to 30% of patients with this rash have an underlying chronic infection like tuberculosis, or an internal tumor. Finding and treating that underlying disease is the most important step for your health, and it will also cause the skin spots to clear up.
Q: Are these circular patches contagious? Can my partner catch them?
A: No. Pityriasis rotunda is not contagious. The patches are not caused by an active skin infection (such as ringworm) and cannot be passed to anyone else. It is a localized reaction of the skin tissue related to systemic health factors, nutrition, or immune changes.
Get the Free 2026 Clinical AI Directory
Email us at caleb@openphr.org to receive our exclusive directory of over 150 open-source models and clinical trial databases.